Egis World

Our products reach 100 countries

Click here to learn more

Pharmaceutical Company

Our activities incorporate all areas in the pharmaceutical value chain

Click here to learn more

Research & Development

One of the fundamental pillars of our strategy is innovation. We have devoted EUR 48 million to research and development.

Click here to learn more
Egis World Pharmaceutical Company R&D
Own subsidiaries / Representative offices
Sales through Partners
Innovation

Egis' medicines won the Innovation Grand Prize

Two of Egis’ fixed-dose combination drugs have won the Innovation Grand Prize. The awarded Egis medicines feature significant innovations as they reduce the risk of cardiovascular events related to atherosclerosis due to the combined lipid-lowering therapy. In respect of these two products the company obtained three patents related to active ingredient development and two patents related to formulation development that are all relevant to large-scale manufacturing technologies. The recognition was not without a history, as this is the tenth time an Egis medicine has received an Innovation Prize or Grand Prize.

More
Egis World

This was the year we commemorated the 110th anniversary of the foundation of our company

Continuous modernisations and investment, launch of a new line of business, tree planting, exhibitions, and a short story contest. In 2023 Egis commemorated its 110th anniversary with a special series of events.

More
Egis World

Professional award for our joint project with the Örkény Theatre

The Art is Business Award recognizes outstanding collaborations between representatives of the corporate sector and the arts scene.

More
More articles

Egis World

Egis’ products reach 100 countries around the world.

Egis’ products reach 100 countries. Our portfolio consists of 653 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Learn more

Healthcare Professionals

and prescription drugs

Professional content for visitors with qualification in medicine or pharmaceuticals This content is only accessible by using your personal password.

Learn more
Therapeutic areas
Therapeutic areas
Cardiovascular system
Central nervous system
Gastroenterology
Oncology
Women´s health

Gallery

Downloads

Our related products

More
Play video
Show gallery
flag
No. of employees
No. of products
Subsidiary/representation was established in
flag
No. of employees
No. of products
Subsidiary/representation was established in

Play video
Show gallery

Play video

Gallery

Downloads

Our related products

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox